Go Pro

Allient (ALNT) Competitors

Allient logo
$102.93 +3.14 (+3.15%)
Closing price 04:00 PM Eastern
Extended Trading
$102.96 +0.03 (+0.03%)
As of 06:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ALNT vs. AVTR, MIR, VNT, TXG, and AEHR

Should you buy Allient stock or one of its competitors? MarketBeat compares Allient with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Allient include Avantor (AVTR), Mirion Technologies (MIR), Vontier (VNT), 10x Genomics (TXG), and Aehr Test Systems (AEHR). These companies are all part of the "measuring and control equipment" industry.

How does Allient compare to Avantor?

Allient (NASDAQ:ALNT) and Avantor (NYSE:AVTR) are both measuring and control equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, valuation, dividends and risk.

Allient has a beta of 1.64, suggesting that its share price is 64% more volatile than the broader market. Comparatively, Avantor has a beta of 0.97, suggesting that its share price is 3% less volatile than the broader market.

In the previous week, Avantor had 2 more articles in the media than Allient. MarketBeat recorded 6 mentions for Avantor and 4 mentions for Allient. Avantor's average media sentiment score of 0.81 beat Allient's score of 0.53 indicating that Avantor is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Allient
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Avantor
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Allient has a net margin of 4.25% compared to Avantor's net margin of -8.42%. Allient's return on equity of 12.47% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Allient4.25% 12.47% 6.37%
Avantor -8.42%9.95%4.78%

61.6% of Allient shares are owned by institutional investors. Comparatively, 95.1% of Avantor shares are owned by institutional investors. 15.0% of Allient shares are owned by insiders. Comparatively, 0.3% of Avantor shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Allient has higher earnings, but lower revenue than Avantor. Avantor is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allient$560.59M3.12$22.03M$1.4371.98
Avantor$6.55B1.03-$530.20M-$0.81N/A

Allient currently has a consensus price target of $77.33, indicating a potential downside of 24.87%. Avantor has a consensus price target of $10.47, indicating a potential upside of 5.72%. Given Avantor's higher possible upside, analysts clearly believe Avantor is more favorable than Allient.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Allient
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
Avantor
3 Sell rating(s)
12 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.94

Summary

Allient beats Avantor on 11 of the 16 factors compared between the two stocks.

How does Allient compare to Mirion Technologies?

Mirion Technologies (NYSE:MIR) and Allient (NASDAQ:ALNT) are both measuring and control equipment companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

In the previous week, Mirion Technologies had 1 more articles in the media than Allient. MarketBeat recorded 5 mentions for Mirion Technologies and 4 mentions for Allient. Mirion Technologies' average media sentiment score of 0.85 beat Allient's score of 0.53 indicating that Mirion Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mirion Technologies
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Allient
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

78.5% of Mirion Technologies shares are held by institutional investors. Comparatively, 61.6% of Allient shares are held by institutional investors. 2.2% of Mirion Technologies shares are held by insiders. Comparatively, 15.0% of Allient shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Allient has a net margin of 4.25% compared to Mirion Technologies' net margin of 2.56%. Allient's return on equity of 12.47% beat Mirion Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Mirion Technologies2.56% 6.44% 3.48%
Allient 4.25%12.47%6.37%

Mirion Technologies has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market. Comparatively, Allient has a beta of 1.64, suggesting that its stock price is 64% more volatile than the broader market.

Mirion Technologies has higher revenue and earnings than Allient. Allient is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mirion Technologies$981M4.59$28.80M$0.10179.62
Allient$560.59M3.12$22.03M$1.4371.98

Mirion Technologies currently has a consensus target price of $27.13, suggesting a potential upside of 51.01%. Allient has a consensus target price of $77.33, suggesting a potential downside of 24.87%. Given Mirion Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe Mirion Technologies is more favorable than Allient.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mirion Technologies
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.80
Allient
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Mirion Technologies beats Allient on 11 of the 17 factors compared between the two stocks.

How does Allient compare to Vontier?

Vontier (NYSE:VNT) and Allient (NASDAQ:ALNT) are both measuring and control equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

Vontier currently has a consensus price target of $42.38, indicating a potential upside of 45.69%. Allient has a consensus price target of $77.33, indicating a potential downside of 24.87%. Given Vontier's higher possible upside, research analysts clearly believe Vontier is more favorable than Allient.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vontier
1 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.40
Allient
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Allient had 2 more articles in the media than Vontier. MarketBeat recorded 4 mentions for Allient and 2 mentions for Vontier. Allient's average media sentiment score of 0.53 beat Vontier's score of 0.00 indicating that Allient is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vontier
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Allient
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

95.8% of Vontier shares are held by institutional investors. Comparatively, 61.6% of Allient shares are held by institutional investors. 1.1% of Vontier shares are held by company insiders. Comparatively, 15.0% of Allient shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Vontier has higher revenue and earnings than Allient. Vontier is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vontier$3.08B1.33$406.10M$2.8310.28
Allient$560.59M3.12$22.03M$1.4371.98

Vontier pays an annual dividend of $0.10 per share and has a dividend yield of 0.3%. Allient pays an annual dividend of $0.16 per share and has a dividend yield of 0.2%. Vontier pays out 3.5% of its earnings in the form of a dividend. Allient pays out 11.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Vontier is clearly the better dividend stock, given its higher yield and lower payout ratio.

Vontier has a beta of 1.16, suggesting that its stock price is 16% more volatile than the broader market. Comparatively, Allient has a beta of 1.64, suggesting that its stock price is 64% more volatile than the broader market.

Vontier has a net margin of 13.37% compared to Allient's net margin of 4.25%. Vontier's return on equity of 37.88% beat Allient's return on equity.

Company Net Margins Return on Equity Return on Assets
Vontier13.37% 37.88% 10.90%
Allient 4.25%12.47%6.37%

Summary

Vontier beats Allient on 11 of the 18 factors compared between the two stocks.

How does Allient compare to 10x Genomics?

10x Genomics (NASDAQ:TXG) and Allient (NASDAQ:ALNT) are both measuring and control equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, media sentiment, profitability and institutional ownership.

10x Genomics has a beta of 2.12, meaning that its share price is 112% more volatile than the broader market. Comparatively, Allient has a beta of 1.64, meaning that its share price is 64% more volatile than the broader market.

84.7% of 10x Genomics shares are owned by institutional investors. Comparatively, 61.6% of Allient shares are owned by institutional investors. 8.8% of 10x Genomics shares are owned by insiders. Comparatively, 15.0% of Allient shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Allient has a net margin of 4.25% compared to 10x Genomics' net margin of -3.55%. Allient's return on equity of 12.47% beat 10x Genomics' return on equity.

Company Net Margins Return on Equity Return on Assets
10x Genomics-3.55% -2.86% -2.23%
Allient 4.25%12.47%6.37%

10x Genomics presently has a consensus target price of $24.00, indicating a potential downside of 37.40%. Allient has a consensus target price of $77.33, indicating a potential downside of 24.87%. Given Allient's stronger consensus rating and higher probable upside, analysts plainly believe Allient is more favorable than 10x Genomics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
10x Genomics
1 Sell rating(s)
10 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.20
Allient
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, 10x Genomics had 4 more articles in the media than Allient. MarketBeat recorded 8 mentions for 10x Genomics and 4 mentions for Allient. 10x Genomics' average media sentiment score of 0.81 beat Allient's score of 0.53 indicating that 10x Genomics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
10x Genomics
3 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Allient
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Allient has lower revenue, but higher earnings than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
10x Genomics$638.78M7.62-$43.54M-$0.17N/A
Allient$560.59M3.12$22.03M$1.4371.98

Summary

Allient beats 10x Genomics on 9 of the 15 factors compared between the two stocks.

How does Allient compare to Aehr Test Systems?

Allient (NASDAQ:ALNT) and Aehr Test Systems (NASDAQ:AEHR) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

In the previous week, Aehr Test Systems had 3 more articles in the media than Allient. MarketBeat recorded 7 mentions for Aehr Test Systems and 4 mentions for Allient. Aehr Test Systems' average media sentiment score of 0.98 beat Allient's score of 0.53 indicating that Aehr Test Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Allient
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aehr Test Systems
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Allient has a net margin of 4.25% compared to Aehr Test Systems' net margin of -25.23%. Allient's return on equity of 12.47% beat Aehr Test Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Allient4.25% 12.47% 6.37%
Aehr Test Systems -25.23%-7.15%-6.15%

Allient has higher revenue and earnings than Aehr Test Systems. Aehr Test Systems is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allient$560.59M3.12$22.03M$1.4371.98
Aehr Test Systems$58.97M51.23-$3.91M-$0.38N/A

Allient currently has a consensus price target of $77.33, suggesting a potential downside of 24.87%. Aehr Test Systems has a consensus price target of $68.00, suggesting a potential downside of 29.21%. Given Allient's stronger consensus rating and higher possible upside, equities analysts plainly believe Allient is more favorable than Aehr Test Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Allient
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
Aehr Test Systems
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

61.6% of Allient shares are owned by institutional investors. Comparatively, 69.7% of Aehr Test Systems shares are owned by institutional investors. 15.0% of Allient shares are owned by company insiders. Comparatively, 6.8% of Aehr Test Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Allient has a beta of 1.64, suggesting that its share price is 64% more volatile than the broader market. Comparatively, Aehr Test Systems has a beta of 3.18, suggesting that its share price is 218% more volatile than the broader market.

Summary

Allient beats Aehr Test Systems on 11 of the 16 factors compared between the two stocks.

Get Allient News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALNT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALNT vs. The Competition

MetricAllientELEC IndustryComputer SectorNASDAQ Exchange
Market Cap$1.75B$7.68B$39.03B$12.60B
Dividend Yield0.16%1.49%3.31%6.21%
P/E Ratio71.9853.6680.6424.89
Price / Sales3.124.35622.30115.42
Price / Cash26.5430.0946.0036.96
Price / Book5.794.569.906.56
Net Income$22.03M$191.40M$1.07B$336.70M
7 Day Performance7.19%0.63%2.52%3.31%
1 Month Performance30.03%-1.46%0.31%1.68%
1 Year Performance183.48%77.43%160.17%31.96%

Allient Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALNT
Allient
3.6742 of 5 stars
$102.93
+3.1%
$77.33
-24.9%
+177.8%$1.75B$560.59M71.982,478
AVTR
Avantor
1.7817 of 5 stars
$9.41
+0.6%
$10.57
+12.3%
-26.1%$6.42B$6.55BN/A13,500
MIR
Mirion Technologies
3.9568 of 5 stars
$18.78
+1.3%
$27.13
+44.4%
-19.9%$4.70B$925.40M187.803,281
VNT
Vontier
3.6877 of 5 stars
$30.21
-0.8%
$42.38
+40.3%
-22.3%$4.25B$3.09B10.677,800
TXG
10x Genomics
1.5893 of 5 stars
$31.87
-3.2%
$23.17
-27.3%
+216.7%$4.05B$642.82MN/A1,240

Related Companies and Tools


This page (NASDAQ:ALNT) was last updated on 6/30/2026 by MarketBeat.com Staff.
From Our Partners